The Center for RNA Biomedicine produces an annual magazine and report, RNA Translated.
March 8, 2024. ANN ARBOR, Mich. The Center for RNA Biomedicine at the University of Michigan is pleased to announce the publication of our latest issue of RNA Translated.
The 2024 issue focuses on our M-RNA Therapeutics Initiative, the scientists at the forefront of RNA research, and the groundbreaking efforts to build a bench-to-bedside pipeline to discover, design, and deliver RNA-based and RNA-targeting therapeutic medicines to treat myriad rare and genetic diseases and conditions.
M-RNA Therapeutics: Changing tomorrow’s world of medicine, today.
In 2020, in the midst of the COVID-19 pandemic, we focused our publication on RNA viruses. With the success of the mRNA vaccines against COVID-19 and the 2020 Nobel Prize in Chemistry about CRISPR, our 2021 issue of RNA Translated looks into three major aspects of RNA therapeutics: mRNA vaccines, ASOs and CRISPR. With this publication we also wish to further support and promote RNA therapeutics research at the U-M.
